The onset time for cholesterol crystal nucleation of supersaturated normal human gallbladder biles is consistently prolonged when compared with biles from patients with cholesterol gallstone disease. Investigation of the factor(s) responsible for the suspended supersaturation (metastability) of normal human biles revealed that model bile solutions of cholesterol saturation index (CSI) and molar lipid composition identical to individual gallbladder bile specimens had much shorter crystal nucleation times, i.e., exhibited decreased metastability. Unsaturated normal biles, after supplementation with lecithin, cholesterol, and sodium taurocholate to a 'standard' supersaturated lipid composition, also demonstrated nucleation times three-to 15-fold longer than the comparable standard model bile. Total lipid extracts of normal biles, however, when similarly supplemented, did not differ in nucleation time from the control model solution. Gallbladder biles were fractionated by gel chromatography and the eluted fractions were pooled into two fractions. The fractions eluting in about the first 25% of the included volume when mixed with the supersaturated standard model bile induced a modest increase in nucleation time of approximately 1.5 times the control value. The fractions eluting in the second 25% of the included volume and which contained all of the bile lipids, were concentrated and supplemented with lipids to the standard composition. The nucleation times of these supplements were 3-10 times longer than the control nucleation times. As bstract. The onset time for cholesterol crystal nucleation of supersaturated normal human gallbladder biles is consistently prolonged when compared with biles from patients with cholesterol gallstone disease. Investigation of the factor(s) responsible for the suspended supersaturation (metastability) of normal human biles revealed that model bile solutions of cholesterol saturation index (CSI) and molar lipid composition identical to individual gallbladder bile specimens had much shorter crystal nucleation times, i.e., exhibited decreased metastability. Unsaturated normal biles, after supplementation with lecithin, cholesterol, and sodium taurocholate to a 'standard' supersaturated lipid composition, also demonstrated nucleation times three-to 15-fold longer than the comparable standard model bile. Total lipid extracts of normal biles, however, when similarly supplemented, did not differ in nucleation time from the control model solution. Gallbladder biles were fractionated by gel chromatography and the eluted fractions were pooled into two fractions. The fractions eluting in about the first 25% of the included volume when mixed with the supersaturated standard model bile induced a modest increase in nucleation time of -1.5 times the control value. The fractions eluting in the second 25% of the included volume and which contained all ofthe bile lipids, were concentrated and supplemented with lipids to the standard composition. The nucleation times of these supPart ofthis work was presented at
Introduction
In a previous report (1) the onset time for cholesterol crystal nucleation in human gallbladder biles was established as an index ofdifferences in metastability (suspended supersaturation).
Nucleation times of supersaturated normal biles were consistently prolonged when compared with biles from patients with cholesterol gallstone disease (abnormals). These findings have been confirmed by two other groups (2, 3) . This distinction in nucleation times could not have been predicted by using differences in cholesterol saturation indices (CSI)' derived from observations with artificial biles (4) . This finding suggested that a nonlipid component might stabilize the supersaturated normal biles. A comparison of solute compositions of normal and abnormal biles, however, revealed no evident difference in the nonlipid components (1) , so the factor(s) responsible for the observed difference in metastability remained obscure.
A possible explanation for the observed difference in metastability has been the recent finding of nucleating (or nucleation-promoting) factor(s) that could account for observed rapid onset time for cholesterol crystal nucleation in biles associated with cholesterol gallstone disease (5-7). Although possibly accounting in part for the difference found between health and disease, the presence of nucleating factors in biles of cholesterol gallstone patients would not explain the prolonged metastability of biles from healthy controls.
In this paper, there are two main objectives. First, experiments were done to unambiguously establish or exclude the presence of metastability-enhancing (nucleation-inhibiting) factors in the biles from healthy controls with biliary cholesterol supersaturation and prolonged metastability. An exact normalization was incorporated into these studies for two important determinants of nucleation time, i.e., percent total solids and CSI. The result of these carefully controlled studies confirm the presence of a nucleation-inhibiting effect conferred by some unidentified factor in normal bile. Second, using conventional fractionation procedures, studies were performed for the preliminary isolation and biochemical characterization of the nucleation-inhibiting factor. Bile proteins were found to consistently exhibit the inhibiting effect, and therefore to contain the factor, whereas bile lipids did not.
Methods
Clinical. Fresh human gallbladder bile specimens were obtained at surgery as previously described (1) or were collected in a similar manner from legally dead, living donors for a renal transplant program. Prior approval of the protocol used in this investigation was obtained from the Clinical Research Projects and Institutional Review Committee regarding human studies. No difference in results was observed between either group of living subjects. The presence ofgallstones in these patients was excluded on the basis of surgical palpation and the absence in the sample of cholesterol crystals by polarizing microscopy (2) .
Gallbladder aspirates were either immediately fractionated or, after removal of aliquots for quantitative analysis, were frozen at -80'C under nitrogen for storage. Cryoprecipitates were not observed after thawing bile samples stored up to 4 mo.
Nucleation times. Nucleation times were determined essentially as previously described (1) . Each heated isotropic mixture was filtered through a detergent-free 0.22-or 0.8-ium filter (Millipore Continental Water Systems, Bedford, MA) into a 2-ml capped glass microvial, gassed with N2, sealed, and placed in a 370C incubator. The time zero for the nucleation time determination was arbitrarily established at 30 min after an initial thermal equilibration. At ['4Cjsucrose (New England Nuclear, Boston, MA), respectively. Essentially all of the biliary lipids and -25% of the protein in this sample eluted at a Kay of -0.45 (Fig. 1) . The lipids in other bile samples eluted similarly under these conditions. 90-100% of the proteins in the native bile sample were recovered. In each experiment the fractions eluting before the lipid peak and containing only protein were pooled, concentrated to the volume of the original bile sample, and designated as fraction A. The native lipid-containing fractions were also pooled, concentrated as above, and these were designated as fraction B. The proportion of the native biliary proteins recovered in fraction A varied from 25 to -75% (0.26-1.95 mg/ml) among the samples tested.
Delipidation ofbiliary proteins by ultracentrifugation. Gallbladder biles were dialyzed (Spectrapor 2, Spectrum Medical, Los Angeles, CA) for 3 d under running cold tap water. Less than 0.1 mM bile salts remained in the dialyzed bile. All buffers used in subsequent fractionations contained 0.15% e-amino caproic acid and 0.13% EDTA. In control nucleation experiments, it was ascertained that neither e-amino caproic acid (0.15%) nor EDTA (0.15%) as well as polyethylene glycol (PEG-8000) (10-100 pg/ml) (Fisher Scientific Co.) had any effect on the nucleation time of the standard model bile.
Detergent-delipidated proteins were prepared using a modification of the method described by Helenius et al. (8) . Octyglucoside (Sigma Chemical Co.) was added to the dialyzed bile at 100 mM, approximately fourfold in excess of the phospholipid concentration. This mixture was incubated with shaking at 370C for 24-36 h. 1 ml of the mixture was layered over 10 ml of 25% sucrose, 0.14 M NaCl, 10 mM Hepes-buffered saline (HBS), 30 mM octylglucoside, pH 7.5, in an ultracentrifuge tube and centrifuged at 200,000 g for 36 h using a SW-41 rotor in a Beckman L5-50 ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, CA). The detergent delipidated proteins sedimented in the bottom two-thirds of the tubes and contained <0.1 mM phospholipids. The phospholipid and protein profile of a typical experiment is shown in Fig. 2 . This profile is representative of those obtained from many delipidation experiments. The cholesterol was always associated with the phospholipid peak. However, the recovery of sedimenting (detergent delipidated) protein varied from 16 to 78% (0.62-5.20 mg/ml) of the protein initially present in the dialyzed bile samples.
The delipidated proteins were dialyzed with HBS, concentrated to original volume using PEG-8000 and stored at -85°C until use (typically within 1 or 2 mo). Other detergents used in this procedure included Cholesterol saturation indices were calculated from critical tables (16) . Weight average molecular weights of 492 and 759 were used for human bile salts and biliary phospholipid, respectively.
Protein assay. Biliary proteins were quantitated fluorometrically by a modified fluorescamine assay (17) . Bile proteins and serum albumin standards were precipitated with 7% trichloroacetic acid (TCA) in 1.5-ml microfuge tubes and the TCA and residual lipids were removed by washing the precipitates twice with ethanol/diethyl ether (1: 1). The precipitates were hydrolyzed in 2.5 N NaOH for 15 h at 1 10C and neutralized with concentrated HCL. The standards and samples were diluted to a concentration from 10 to 100 Ag/ml with borate buffer (0.2 M sodium borate, 0.5% sodium dodecyl sulfate [SDS], pH 8.5). Between 0.025 and 0.100 ml of diluted sample or standard in a 12 X 75-mm borosilicate glass tube was vortexed and 0.100 ml of fluorescamine solution (0.3 mg/ml) (Sigma Chemical Co.) was added during mixing. The mixtures were brought to a total volume of 3.0 ml, mixed, and the relative fluorescence was measured using a Turner model III fluorometer (Turner Designs, Mountain View, CA) equipped with a 405-nm excitation filter and a Wratten No. 3 emission filter. This procedure was the only protein assay that provided an accurate quantitation (by weight) of protein in bile and was calibrated by amino acid analysis. All other conventional protein assays were affected by interference or cross-reactivity with phospholipids, bile salts, or bile pigments. The total protein concentration of the native gallbladder biles in this study had a mean concentration (±SD) of 7.1±5.5 mg/ml (n = 12).
Protein electrophoretic studies. SDS-polyacrylamide slab gels were run in the buffer system described by Laemmli (18) . The apparatus was similar in design to that of Reid and Bieleski (19 of Merril et al. (21) . Purified proteins were used as standards (Pharmacia Fine Chemicals, Piscataway, NJ). Experimental protocol. Three different in vitro functional assay approaches were utilized in this study, matching supplementation and recombination. In the matching experiments, model biles were constructed from purified cholesterol, phosphatidylcholine, and bile salt having an identical molar lipid composition and percent total lipids to that of a given supersaturated normal human bile. The nucleation times of the native and matched model biles were then determined. In the supplementation experiments native bile samples were supplemented with sufficient purified model bile lipids to achieve a final lipid composition consisting of 20% total solids and a CSI of 1.17 in the physiologic range of biliary lipid composition. The nucleation times under these conditions were rigorously observed between the supplemented native biles and control model biles of the same lipid composition. The third approach involved a recombination of delipidated native bile proteins with a standard model bile as described below. Nucleation times were then compared between the recombined and control samples.
Matching experiments. A model bile was constructed using a combination ofmethods previously described (18, 19) , with recent refinements recommended by Carey and Small (4) (Fig. 3) .
Supplementation experiments. The cholesterol phospholipid and total bile acid composition ofunsaturated normal biles, total lipid extracts, and chromatographic fraction B (see below) were first determined. A lipid supplement mixture of sodium taurocholate, egg lecithin, and cholesterol stock solutions was placed in a 3-ml capped glass vial, dried, and lyophilized. The composition of the supplement lipids was calculated so that, when brought to a final volume of 1.0 ml, using the native sample as a modification of diluent, the final total lipid composition of each mixture would be: 8. Matching experiments. The lipid composition and nucleation time of aliquots of fresh normal human gallbladder biles (n = 8) was determined at 370C. The nucleation times of these biles ranged from 55 to 200 h. Model biles, consisting of purified lecithin, cholesterol, and sodium taurocholate, were then prepared in order to match each human bile for molar composition of the three lipids. A comparison of the nucleation times for each matched pair is shown in Fig. 4 . The lipid compositions of the native and model biles that correspond in numerical sequence to the nucleation times of Fig. 4 
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The nucleation times of the native biles were from three-to 40-fold longer than those of the matched model biles. Supplementation experiments. An alternative procedure for evaluation of metastability was to supplement biliary lipid-containing samples with purified model bile lipids to achieve a similar standard lipid composition. This approach is especially useful and even essential with human bile samples that are undersaturated with cholesterol. Supplementation of normal biles to equivalent CSI and total lipid concentration (Table II A) was achieved and resulted in solutions of comparable degrees of supersaturation. The nucleation times of these solutions, however, were strikingly prolonged when compared with a stan- dard model bile of similar composition (Fig. 5) . Nucleation times of the supplemented normal biles shown in Fig. 5 correspond in numerical sequence to the compositional data shown in Table II A) . Bile can be deproteinized by extraction of the lipids with 2:1 chloroform/methanol or 1:1 ethanol/ether, drying, and reconstitution in aqueous solution. Lipid extracts from normal gallbladder biles were thus prepared and supplemented to the standard lipid composition as previously described (Table II B) . The nucleation times of the resulting supplements were determined. plemented to the standard lipid composition (Table II B) , as previously described, and their nucleation times were determined (Fig. 6) . The lipid compositions of the B fractions and of the final supplements are shown in Table III , the numerical sequence of which correspond to the nucleation time observations indicated in Fig. 6 . All such supplements demonstrated prolonged nucleation times compared with the controls. Recombination experiments. Sedimented (detergent delipidated) proteins were prepared from normal gallbladder biles that were dialyzed free of detergent and concentrated to the original sample volume. These fractions were recombined with standard model biles and the nucleation times of the mixtures were determined. All samples had substantially longer nucleation times when compared with the control model bile (Fig. 7) . When detergent delipidated bile proteins were preincubated with pronase, and subsequently recombined with standard model bile lipids, the observed nucleation time for the mixture was that of the control (12 h). The nucleation times of the recombined mixture containing unpretreated protein and of the lipids recombined only with saline were 41 and 17 h, respectively. Pronase alone did not affect the nucleation time of the standard model bile. As a further protein control, human serum albumin (Calbiochem-Behring Corp.) was recombined with standard model bile using the bile protein recombination technique previously described in a concentration series encompassing the range of 50 to 2,000 ,g/ml-'. The observed nucleation time for these mixtures was not different from that of the control.
Fraction A proteins from six normal biles were dialyzed and recombined with standard model bile lipids and the nucleation times of the mixtures are given in Fig. 8 . There is a modest but consistent prolongation of nucleation time in the mixtures ranging up to threefold the control nucleation time. No correlation Qualitative analysis, by thin-layer chromatography ofmodel bile lipids, following recombination experiments in which inhibition of nucleation time was observed, showed no significant differences between lipids exposed to delipidated proteins and to saline control solutions. Thus, model bile lipid degradation does not occur to an appreciable extent during the course of nucleation time assays.
Characterization of the bile proteins. Differences in the character of the proteins found in fractions A and B are demonstrated in the electrophoretic gel shown in Fig. 9 . Although there is overlap, the proteins found in fraction A show a distinct trend toward larger molecular weights when compared with those in fraction B. From an overview standpoint, in Fig. 10 A is shown an analytical isoelectrofocusing gel of delipidated fraction B proteins. Further, in Fig. 10 monstrable from the combination of these techniques is the inherent complexity of the bile proteins.
Discussion
Cholesterol crystal nucleation, the crucial first step in the process of gallstone formation in bile, does not occur simply as predicted from studies of model solutions (4) . In normal gallbladder bile there is a significant retardation or inhibition of nucleation as indicated by observations of its delayed onset time when compared with control model systems (Fig. 3 ). These observations are definitively established in the matching and supplementation studies of the present work (Figs. 4 and 5) . Nucleation inhibitory factor. Since the crystal nucleation inhibitory effect is not found in model biles composed only of the primary biliary lipids, a reasonable deduction has been that the chemical nature of the inhibitor is not that of a lipid. Such an expectation was borne out in the present studies by a failure to demonstrate an inhibitory effect using the present in vitro functional assay system with total biliary lipid extracts under controlled conditions (Fig. 5) .
Although bile proteins comprise <5% of the total biliary solid content, as a class they represent the next most abundant solute, second only to the biliary lipids (1). Thus, despite their comparatively low concentration in bile, it was natural to wonder whether the bile proteins could have a crystal nucleation inhibitory effect. If the proteins of bile play a role in metastable supersaturation of cholesterol, the first requirement is that they form complexes or otherwise physically interact in some way with bile lipids. This is suggested by analogy with serum lipoproteins. The existence of lipoprotein complexes in bile has been previously suggested but not proven by a number ofworkers (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . The presence of an inhibitory effect was demonstrable in the present study in several fractions of delipidated bile proteins (Figs. 7 and 8) as well as a fraction of lipid-containing bile protein (Fig. 6 ). These findings neither conclusively demonstrate the presence of a bile lipoprotein complex as a valid entity nor exclude the possibility that there could also be some additional contribution to the naturally occurring nucleation-inhibiting effect seen in bile from some as yet unidentified solute. They do indicate, however, that the predominant nucleation inhibitory factor probably represents a subfraction of bile proteins interacting with bile lipids. This view is further strengthened by the observations that pronase treatment completely abolished the nucleation inhibitory effect. Regarding the presently demonstrated nucleation inhibitory effect of proteins, one could reasonably wonder whether this is merely a general effect of proteins or a specific effect of bile proteins. The lack of a demonstrable effect for albumin indicated as a control for the detergent delipidation protein recombination experiments (Fig. 7) supports the view that the bile protein effect is probably specific.
Ofthe gel chromatography fractions, a less potent inhibitory effect was found in the fraction eluting between the excluded volume limit and the biliary lipids (Figs. 1 and 8) . A more potent inhibitory effect was found in the bile protein fraction exhibiting an apparently greater degree of lipid association during elution (Figs. 1 and 6 Relevance to other nucleation studies. The observation of a sharp discrimination between normal and abnormal biles in the basis of nucleation time originally reported by us has now been confirmed by others (2, 3, 5) . Much ofthe focus ofattention in these studies has been on the potential presence of nucleating agents in the abnormal biles to account for the remarkably shortened nucleation times observed. A recent study, moreover, has demonstrated that the potency of this apparent nucleating factor is great (5) . Although the biochemical nature ofthis factor remains to be determined, it is assumed to be produced within the gallbladder and appears not to be a gallbladder mucosaderived mucin (3) . By contrast, in the prairie dog model, recent studies have suggested a role for mucosal-derived gallbladder mucin as a nucleating agent. The relevance of these findings to the pathogenesis of human gallstones, however, remains unestablished (6, 7) . Evidence provided in this study for a crystal nucleation inhibitor normally present in human bile justifies speculation that in disease the inhibitor could be either absent, blocked, or inactivated. Several papers have appeared in the literature that describe specific proteins having an effect on crystallization phenomena in solutions of biological interest (35) (36) (37) (38) . The mechanism(s) whereby these proteins exert their effects probably differ considerably from the effect of bile proteins. This is because they affect ionic electrolyte solutions rather than predominantly micellar solutions and because their effects are more probably on inhibition of crystal growth, rather than on crystal nucleation per se.
We conclude that patients without gallstone disease have a cholesterol crystal nucleation inhibitor that is predominantly derived from bile proteins. This finding affords an explanation for the prolonged metastability found in normal human bile, especially in the presence of marked biliary cholesterol supersaturation. The precise mechanism whereby the inhibitory effect is mediated remains unclear and this may be of fundamental importance to both the definition ofhealth and the pathogenesis of cholesterol gallstone disease.
